Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GLG | Ann: Removal from Official List | 25/10/12 | 0 | 965 | |||
|
|||||||
GLG | Ann: Scheme Implementation - Resignation of Direc | 23/10/12 | 0 | 821 | |||
|
|||||||
GLG | Ann: Appendix 3Z - Final Director's Interest | 23/10/12 | 0 | 793 | |||
|
|||||||
AMP +GLG | Ann: Ceasing to be a substantial holder from AMP | 16/10/12 | 0 | 866 | |||
|
|||||||
GLG | Ann: Suspension from Official Quotation | 11/10/12 | 0 | 1.2K | |||
|
|||||||
GLG | Ann: Lodgement of Court Orders with ASIC | 11/10/12 | 0 | 652 | |||
|
|||||||
GLG | Ann: Federal Court Approves Scheme | 10/10/12 | 0 | 671 | |||
|
|||||||
GLG | Ann: Scheme Meeting Results | 05/10/12 | 0 | 709 | |||
|
See All Discussions